BCG vaccination, and especially developing BCG disease, confers a greater protection against EM disease than against TB in IL-12Rβ1-deficient patients despite the close phylogenetic relationship between BCG and MTB, presumably because MTB is more virulent than EM (de Beaucoudrey et al. 2010). This evidence concerns the gene IL12RB1 and tuberculosis.